Kidney failure and kidney transplants may increase the risk of certain cancers, a new study suggests.
A poor kidney and a drug that inhibits the immune system may increase the risk of kidney cancer, says Elizabeth Yanik, who works for the national cancer institute.
The research articles published in the November 12, the journal of the American society of Nephrology (Nephrology), the researchers for more than 200000 U.S. renal transplant candidates and recipients of the relevant data is studied.
Study found that kidney transplant candidates and recipients of increased risk of certain types of cancer, the researchers also found that the different types of corresponding high risk of cancer treatment. However, it does not prove causation.
The risk of kidney and thyroid cancer is particularly high in patients with renal failure after dialysis. Non-hodgkin lymphoma, lung cancer, melanoma and certain other types of skin cancer risk were highest in patients with kidney transplants. The reasons for this phenomenon may be drugs suppress the immune system function, the author of the study suggest that patients must try to reject this treatment for kidney transplantation.
"Our study suggests that kidney disease patients in the treatment of the later period of the need for cancer screening, and take some preventive measures, but the situation of the disease may vary from person to person," said in a press release Yanik, she who works at the American society of nephrology.
"For kidney transplant patients, wary of kidney and thyroid cancer may be particularly important. After renal transplantation patients with immunosuppressive drugs, or may require additional attention to melanoma lung cancer screening," she concluded.
The findings suggest that medical workers need to keep an eye on cancer risk in patients with kidney transplants, Yanik's team said.